A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA; DESCARTES Investigators.
N Engl J Med. 2014 May 8;370(19):1809-19. doi: 10.1056/NEJMoa1316222. Epub 2014 Mar 29.
Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding.
Yu F, Wang Z, Zhang T, Chen X, Xu H, Wang F, Guo L, Chen M, Liu K, Wu B.
Nat Commun. 2021 Sep 7;12(1):5323. doi: 10.1038/s41467-021-25674-5.
Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
Zheng ZG, Zhu ST, Cheng HM, Zhang X, Cheng G, Thu PM, Wang SP, Li HJ, Ding M, Qiang L, Chen XW, Zhong Q, Li P, Xu X.
Autophagy. 2021 Jul;17(7):1592-1613. doi: 10.1080/15548627.2020.1757955. Epub 2020 May 20.
A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial.
Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC.
Ann Intern Med. 2004 May 18;140(10):769-77. doi: 10.7326/0003-4819-140-10-200405180-00006.
Vitamin D Supplementation Reduces Hyperlipidemia and Improves Bone Mass in Pediatric Obesity.
Wang F, Bei L, Zhang X, Fu Y.
Crit Rev Immunol. 2025;45(1):31-39. doi: 10.1615/CritRevImmunol.2024052129.
Myofibroblasts: A New Factor Affecting the Hyperlipidemia-Induced Elastic Abnormality of Corpus Cavernosum in Rabbits Detected by 2-D Shear Wave Elastography.
Rao WT, Jiang S, Shen YH, Wang YH, Liu SN, Tang JD, Xing JF.
Ultrasound Med Biol. 2023 Nov;49(11):2336-2345. doi: 10.1016/j.ultrasmedbio.2023.07.010. Epub 2023 Aug 4.
Coagulopathy and the prognostic potential of D-dimer in hyperlipidemia-induced acute pancreatitis.
Yang N, Zhang DL, Hao JY.
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):633-41. doi: 10.1016/s1499-3872(15)60376-9.
Gallbladder disease in hyperlipoproteinaemia.
Einarsson K, Hellström K, Kallner M.
Lancet. 1975 Mar 1;1(7905):484-7. doi: 10.1016/s0140-6736(75)92831-7.
Analysis of the clinical profile and treatment efficiency of hyperlipidemic acute pancreatitis.
Zhou W, Liu Q, Wang Z, Yao L, Chen J, Yang X.
Lipids Health Dis. 2024 Mar 8;23(1):70. doi: 10.1186/s12944-024-02057-5.
Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
Steve Tsang CC, Wan JY, Chisholm-Burns MA, Li M, Dagogo-Jack S, Cushman WC, Hines LE, Wang J.
Res Social Adm Pharm. 2021 Aug;17(8):1469-1477. doi: 10.1016/j.sapharm.2020.11.002. Epub 2020 Nov 10.
